This is a match-making section for JPIAMR 17th call - AMR Interventions 2024 (IMPACT).
Human Health
Animal Health (incl. wildlife, livestock, acquatic organisms, and companion animals)Novel therapeutic reagent; empty viral capsid; multi-targeting; sepsis
We are developing a novel therapeutic reagent. In our studies on sepsis-induced ARDS (Ben-Nun-Shaul 2020, Oncotarget 11:574-588) we discovered that our reagent functions by activating multiple defense pathways within the host, including iNOS and defensin, thus directly killing infecting pathogens. Unlike bacteria, which have a short life span and and a high mutability, the host pathways are fairly stable. We therefore anticipate that the reagent will not be affected by antimicrobial resistance nor lead to the emergence of resistant pathogen strains. In addition, we anticipate that the reagent will not be limited to a single strain or class of pathogens.
We would like to join a project which compares strategies for fighting AMR, preferably using the same pre-clinical model(s) and by exchanging material.
Submitted on 2024-02-26 12:04:14
« Return to the partner search tool